MHC class II (MHC-II) molecules associate with a chaperone protein termed the Invariant chain (Ii) that facilitates the transport of newly synthesized MHC-II to endo/lysosomal antigen processing compartments. Expression of Ii is required for APCs to stimulate most, but certainly not all, antigen-specific T cells. It is thought that these Ii-independent antigens are presented by pre-existing peptide-loaded MHC-II (pMHC-II) that internalize from the plasma membrane, enter into endosomal compartments, exchange old peptides for new antigenic peptides, and then recycle back to the plasma membrane for presentation to CD4 T cells. We have recently shown that unlike Ii-associated MHC-II, pre-existing pMHC-II on the plasma membrane rapidly internalizes into APCs and is returned to the plasma membrane following an Arf6, Rab35, and EHD1-dependent recycling pathway, thereby revealing the molecular machinery responsible for pMHC-II recycling in APCs. In most APCs, the endo/lysosomal antigen processing compartments have properties of multivesicular bodies (MVBs). MVBs are formed by the invagination of the limiting membrane of the organelle, giving rise to a ≈500 nm structure filled with 50-100 nm vesicles. Curiously, MHC-II is present primarily on the intralumenal vesicles of MVB and it is thought that the sorting of MHC-II into these intralumenal vesicles is essential for proper MHC-II-peptide loading. The sorting signals that direct MHC-II onto the intralumenal vesicles of MVB have not been identified, and we will identify these signals and determine the extent to which specific recognition proteins (such as ESCRT), lipids (such as cholesterol or lysobisphosphatidic acid, LBPA), or post-translational modifications of MHC-II (such as ubiquitination) regulate MHC-II entry and/or exit from these compartments for antigen loading.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC009404-14
Application #
7732953
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2008
Total Cost
$504,033
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Anderson, Howard A; Roche, Paul A (2015) MHC class II association with lipid rafts on the antigen presenting cell surface. Biochim Biophys Acta 1853:775-80
Berger, Adam C; Roche, Paul A (2009) MHC class II transport at a glance. J Cell Sci 122:1-4
Bryceson, Yenan T; Rudd, Eva; Zheng, Chengyun et al. (2007) Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 110:1906-15
Muntasell, Aura; Berger, Adam C; Roche, Paul A (2007) T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes. EMBO J 26:4263-72
Puri, Niti; Roche, Paul A (2006) Ternary SNARE complexes are enriched in lipid rafts during mast cell exocytosis. Traffic 7:1482-94
Roche, Paul A (2006) Gold-plating MHC class II molecules. Nat Chem Biol 2:178-9
Poloso, Neil J; Muntasell, Aura; Roche, Paul A (2004) MHC class II molecules traffic into lipid rafts during intracellular transport. J Immunol 173:4539-46
Poloso, Neil J; Roche, Paul A (2004) Association of MHC class II-peptide complexes with plasma membrane lipid microdomains. Curr Opin Immunol 16:103-7
Hiltbold, Elizabeth M; Poloso, Neil J; Roche, Paul A (2003) MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse. J Immunol 170:1329-38
Puri, Niti; Kruhlak, Michael J; Whiteheart, Sidney W et al. (2003) Mast cell degranulation requires N-ethylmaleimide-sensitive factor-mediated SNARE disassembly. J Immunol 171:5345-52

Showing the most recent 10 out of 17 publications